Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations

References

• Alzheimer’s Association. (2014). 2014 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 10, 47–92.
   PubMed Web of Science ®Google Scholar
• Atanasova, M., Stavrakov, G., Philipova, I., Zheleva, D., Yordanov, N., & Doytchinova, I. (2015). Galantsamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity. Bioorganic & Medicinal Chemistry, 23, 5382–5389.10.1016/j.bmc.2015.07.058
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay, S., & Rogers, J. T. (2014). Alzheimer’s disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis. Biochemical Pharmacology, 88, 486–494.10.1016/j.bcp.2014.01.032
   PubMed Web of Science ®Google Scholar
• Bourne, Y., Radić, Z., Sulzenbacher, G., Kim, E., Taylor, P., & Marchot, P. (2006). Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding. Journal of Biological Chemistry, 281, 29256–29267.10.1074/jbc.M603018200
   PubMed Web of Science ®Google Scholar
• Burns, A., & Iliffe, S. (2009). Alzheimer’s disease. British Medical Journal, 338, 467–471.
   Web of Science ®Google Scholar
• Butina, D., Segall, M. D., & Frankcombe, K. (2002). Predicting ADME properties in silico: Methods and models. Drug Discovery Today, 7, S83–S88.10.1016/S1359-6446(02)02288-2
   PubMed Web of Science ®Google Scholar
• Castro, D. M., Dillon, C., Machnicki, G., & Allegri, R. F. (2010). The economic cost of Alzheimer’s disease. Dementia & Neuropsychologia, 4, 262–267.10.1590/S1980-57642010DN40400003
   PubMedGoogle Scholar
• Chen, Y., Fang, L., Peng, S., Liao, H., Lehmann, J., & Zhang, Y. (2012). Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques. Bioorganic & Medicinal Chemistry Letters, 22, 3181–3187.10.1016/j.bmcl.2012.03.046
   PubMed Web of Science ®Google Scholar
• Chen, Y., Liu, Z. L., Fu, T. M., Li, W., Xu, X. L., & Sun, H. P. (2015). Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening. Bioorganic & Medicinal Chemistry Letters, 25, 3442–3446.10.1016/j.bmcl.2015.07.026
   PubMed Web of Science ®Google Scholar
• Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., & Height, J. J. (2012). Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry, 55, 10282–10286.10.1021/jm300871x
   PubMed Web of Science ®Google Scholar
• Crichton, G. E., Bryan, J., & Murphy, K. J. (2013). Dietary antioxidants, cognitive function and dementia – A systematic review. Plant Foods for Human Nutrition, 68, 279–292.10.1007/s11130-013-0370-0
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20, 647–671.10.1007/s10822-006-9087-6
   PubMed Web of Science ®Google Scholar
• Fang, L., Fang, X., Gou, S., Lupp, A., Lenhardt, I., Sun, Y., & Fleck, C. (2014). Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents. European Journal of Medicinal Chemistry, 76, 376–386.10.1016/j.ejmech.2014.02.035
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49, 6177–6196.10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gandy, S., & DeKosky, S. T. (2013). Toward the treatment and prevention of Alzheimer’s disease: Rational strategies and recent progress. Annual Review of Medicine, 64, 367.10.1146/annurev-med-092611-084441
   PubMed Web of Science ®Google Scholar
• Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2011). Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chemical Neuroscience, 3, 50–68.
   PubMed Web of Science ®Google Scholar
• Ghosh, A. K., Gemma, S., & Tang, J. (2008). β-Secretase as a therapeutic target for Alzheimer’s disease. Neurotherapeutics, 5, 399–408.10.1016/j.nurt.2008.05.007
   PubMed Web of Science ®Google Scholar
• Gupta, S. & Mohan, C. G. (2011). 3D-pharmacophore model based virtual screening to identify dual-binding site and selective acetylcholinesterase inhibitors. Medicinal Chemistry Research, 20, 1422–1430.10.1007/s00044-010-9373-7
   Web of Science ®Google Scholar
• Hall, A., & Patel, T. R. (2014). γ-secretase modulators: Current status and future directions. Progress in Medicinal Chemistry, 53, 101.10.1016/B978-0-444-63380-4.00003-2
   PubMedGoogle Scholar
• Han, S., Sweeney, J., Bachman, E. S., Schweiger, E., Forloni, G., Coyle, J., & Joullie, M. (1992). Chemical and pharmacological characterization of galanthamine, an acetylcholinesterase inhibitor, and its derivatives. A potential application in Alzheimer’s disease? European Journal of Medicinal Chemistry, 27, 673–687.10.1016/0223-5234(92)90087-H
   Web of Science ®Google Scholar
• Herlem, D., Martin, M. T., Thal, C., & Guillou, C. (2003). Synthesis and structure-activity relationships of open D-Ring galanthamine analogues. Bioorganic & Medicinal Chemistry Letters, 13, 2389–2391.10.1016/S0960-894X(03)00397-4
   PubMed Web of Science ®Google Scholar
• Huang, Y., & Mucke, L. (2012). Alzheimer mechanisms and therapeutic strategies. Cell, 148, 1204–1222.10.1016/j.cell.2012.02.040
   PubMed Web of Science ®Google Scholar
• Jackisch, R., Förster, S., Kammerer, M., Rothmaier, A. K., Ehret, A., Zentner, J., & Feuerstein, T. J. (2009). Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex. Journal of Alzheimer’s Disease, 16, 635–647.
   PubMed Web of Science ®Google Scholar
• Jia, P., Sheng, R., Zhang, J., Fang, L., He, Q., Yang, B., & Hu, Y. (2009). Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry, 44, 772–784.10.1016/j.ejmech.2008.04.018
   PubMed Web of Science ®Google Scholar
• Jiang, L., & Rizzo, R. C. (2014). Pharmacophore-based similarity scoring for DOCK. The Journal of Physical Chemistry B, 119, 1083–1102.
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L. (2009). Efficient drug lead discovery and optimization. Accounts of Chemical Research, 42, 724–733.10.1021/ar800236t
   PubMed Web of Science ®Google Scholar
• Kidd, P. M. (2008). Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Alternative Medicine Review, 13, 85–115.
   PubMed Web of Science ®Google Scholar
• Lannfelt, L., Relkin, N., & Siemers, E. (2014). Amyloid-ß-directed immunotherapy for Alzheimer’s disease. Journal of Internal Medicine, 275, 284–295.10.1111/joim.12168
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17.10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Malik, R., Sangwan, A., Saihgal, R., Jindal, D. P., & Piplani, P. (2007). Towards better brain management: Nootropics. Current Medicinal Chemistry, 14, 123–131.10.2174/092986707779313408
   PubMed Web of Science ®Google Scholar
• Mantoani, S. P., Chierrito, T. P., Vilela, A. F., Cardoso, C. L., Martínez, A., & Carvalho, I. (2016). Novel triazole-quinoline derivatives as selective dual binding site acetylcholinesterase inhibitors. Molecules, 21, 1–12.10.3390/molecules21020193
   Web of Science ®Google Scholar
• Medina, M., & Avila, J. (2014). New perspectives on the role of tau in Alzheimer's disease. Implications for therapy. Biochemical Pharmacology, 88, 540–547.10.1016/j.bcp.2014.01.013
   PubMed Web of Science ®Google Scholar
• Mehta, M., Adem, A., & Sabbagh, M. (2012). New acetylcholinesterase inhibitors for Alzheimer’s disease. International Journal of Alzheimer’s Disease, 2012, 1–8.
   Google Scholar
• Nogara, P. A., Saraiva, R. D. A., Caeran Bueno, D., Lissner, L. J., Lenz Dalla Corte, C., Braga, M. M., & Rocha, J. B. T. (2015). Virtual screening of acetylcholinesterase inhibitors using the lipinski’s rule of five and ZINC databank. BioMed Research International, 2015, 1–8.
   Web of Science ®Google Scholar
• Prince, M., Albanese, E., Guerchet, M., & Prina, M. (2014). Dementia and risk reduction: An Analysis of protective and modifiable factors, World Alzheimer's Report 2014. London: Alzheimer's Disease International.
   Google Scholar
• Qaseem, A., Snow, V., Cross, J. T., Forciea, M. A., Hopkins, R., Shekelle, P., & Campos-Outcalt, D. (2008). Current pharmacologic treatment of dementia: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of Internal Medicine, 148, 370–378.10.7326/0003-4819-148-5-200803040-00008
   PubMed Web of Science ®Google Scholar
• Salam, N. K., Nuti, R., & Sherman, W. (2009). Novel method for generating structure-based pharmacophores using energetic analysis. Journal of Chemical Information and Modeling, 49, 2356–2368.10.1021/ci900212v
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27, 221–234.10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Schelterns, P., & Feldman, H. (2003). Treatment of Alzheimer’s disease; current status and new perspectives. The Lancet Neurology, 2, 539–547.
   PubMed Web of Science ®Google Scholar
• Sopkova-de Oliveira Santos, J., Lesnard, A., Agondanou, J. H., Dupont, N., Godard, A. M., Stiebing, S., & Bureau, R. (2010). Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library. Journal of Chemical Information and Modeling, 50, 422–428.10.1021/ci900491t
   PubMed Web of Science ®Google Scholar
• Stavrakov, G., Philipova, I., Zheleva, D., Atanasova, M., Konstantinov, S., & Doytchinova, I. (2016). Docking-based design of galantamine derivatives with dual-site binding to acetylcholinesterase. Molecular Informatics, 35, 278–285.10.1002/minf.v35.6-7
   PubMed Web of Science ®Google Scholar
• Sukumaran, S. D., Chee, C. F., Viswanathan, G., Buckle, M. J., Othman, R., Abd Rahman, N., & Chung, L. Y. (2016). Synthesis, biological evaluation and molecular modelling of 2′-hydroxychalcones as acetylcholinesterase inhibitors. Molecules, 21, 1–10.10.3390/molecules21070955
   Web of Science ®Google Scholar
• Thomas, D., Karle, C., & Kiehn, J. (2006). The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Current Pharmaceutical Design, 12, 2271–2283.10.2174/138161206777585102
   PubMed Web of Science ®Google Scholar
• Vigneault, P., Bourgault, S., Kaddar, N., Caillier, B., Pilote, S., Patoine, D., & Drolet, B. (2012). Galantamine (Reminyl®) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current. European Journal of Pharmacology, 681, 68–74.10.1016/j.ejphar.2012.02.002
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2012). Global Health and Aging:2011. Geneva: Author.
   Google Scholar
• Yamashita, F., & Hashida, M. (2004). In silico approaches for predicting ADME properties of drugs. Drug Metabolism and Pharmacokinetics, 19, 327–338.10.2133/dmpk.19.327
   PubMedGoogle Scholar